Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for TFDP1
Z-value: 4.15
Motif logo
Transcription factors associated with TFDP1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
TFDP1
|
ENSG00000198176.8 | transcription factor Dp-1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| TFDP1 | hg19_v2_chr13_+_114238997_114239077 | 0.76 | 9.8e-05 | Click! |
Activity profile of TFDP1 motif
Sorted Z-values of TFDP1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr17_+_42634844 | 14.49 |
ENST00000315323.3
|
FZD2
|
frizzled family receptor 2 |
| chr17_+_47074758 | 9.83 |
ENST00000290341.3
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1 |
| chr11_-_115375107 | 9.11 |
ENST00000545380.1
ENST00000452722.3 ENST00000537058.1 ENST00000536727.1 ENST00000542447.2 ENST00000331581.6 |
CADM1
|
cell adhesion molecule 1 |
| chr8_-_67525473 | 8.06 |
ENST00000522677.3
|
MYBL1
|
v-myb avian myeloblastosis viral oncogene homolog-like 1 |
| chr2_+_36582857 | 7.83 |
ENST00000280527.2
|
CRIM1
|
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
| chr8_-_67525524 | 7.51 |
ENST00000517885.1
|
MYBL1
|
v-myb avian myeloblastosis viral oncogene homolog-like 1 |
| chr17_+_48638371 | 7.25 |
ENST00000360761.4
ENST00000352832.5 ENST00000354983.4 |
CACNA1G
|
calcium channel, voltage-dependent, T type, alpha 1G subunit |
| chr17_+_64961026 | 7.16 |
ENST00000262138.3
|
CACNG4
|
calcium channel, voltage-dependent, gamma subunit 4 |
| chr4_-_175443484 | 6.92 |
ENST00000514584.1
ENST00000542498.1 ENST00000296521.7 ENST00000422112.2 ENST00000504433.1 |
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD) |
| chr11_-_19263145 | 6.89 |
ENST00000532666.1
ENST00000527884.1 |
E2F8
|
E2F transcription factor 8 |
| chr17_-_38574169 | 6.78 |
ENST00000423485.1
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa |
| chr9_+_126773880 | 6.63 |
ENST00000373615.4
|
LHX2
|
LIM homeobox 2 |
| chr4_-_175443943 | 6.50 |
ENST00000296522.6
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD) |
| chr12_+_98909351 | 6.29 |
ENST00000343315.5
ENST00000266732.4 ENST00000393053.2 |
TMPO
|
thymopoietin |
| chr7_-_27183263 | 6.26 |
ENST00000222726.3
|
HOXA5
|
homeobox A5 |
| chr12_+_52445191 | 6.06 |
ENST00000243050.1
ENST00000394825.1 ENST00000550763.1 ENST00000394824.2 ENST00000548232.1 ENST00000562373.1 |
NR4A1
|
nuclear receptor subfamily 4, group A, member 1 |
| chr5_-_172662303 | 6.01 |
ENST00000517440.1
ENST00000329198.4 |
NKX2-5
|
NK2 homeobox 5 |
| chr2_+_174219548 | 5.99 |
ENST00000347703.3
ENST00000392567.2 ENST00000306721.3 ENST00000410101.3 ENST00000410019.3 |
CDCA7
|
cell division cycle associated 7 |
| chr19_+_36359341 | 5.98 |
ENST00000221891.4
|
APLP1
|
amyloid beta (A4) precursor-like protein 1 |
| chr17_-_74733404 | 5.97 |
ENST00000508921.3
ENST00000583836.1 ENST00000358156.6 ENST00000392485.2 ENST00000359995.5 |
SRSF2
|
serine/arginine-rich splicing factor 2 |
| chr19_+_34287174 | 5.90 |
ENST00000587559.1
ENST00000588637.1 |
KCTD15
|
potassium channel tetramerization domain containing 15 |
| chr4_-_175443788 | 5.89 |
ENST00000541923.1
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD) |
| chr11_+_85956182 | 5.83 |
ENST00000327320.4
ENST00000351625.6 ENST00000534595.1 |
EED
|
embryonic ectoderm development |
| chr2_+_239756671 | 5.65 |
ENST00000448943.2
|
TWIST2
|
twist family bHLH transcription factor 2 |
| chr17_-_42276574 | 5.49 |
ENST00000589805.1
|
ATXN7L3
|
ataxin 7-like 3 |
| chr17_+_38444115 | 5.47 |
ENST00000580824.1
ENST00000577249.1 |
CDC6
|
cell division cycle 6 |
| chr13_+_100634004 | 5.43 |
ENST00000376335.3
|
ZIC2
|
Zic family member 2 |
| chr1_+_62902308 | 5.39 |
ENST00000339950.4
|
USP1
|
ubiquitin specific peptidase 1 |
| chr4_-_18023350 | 5.38 |
ENST00000539056.1
ENST00000382226.5 ENST00000326877.4 |
LCORL
|
ligand dependent nuclear receptor corepressor-like |
| chrX_-_15872914 | 5.32 |
ENST00000380291.1
ENST00000545766.1 ENST00000421527.2 ENST00000329235.2 |
AP1S2
|
adaptor-related protein complex 1, sigma 2 subunit |
| chr1_-_226496772 | 5.30 |
ENST00000359525.2
ENST00000460719.1 |
LIN9
|
lin-9 homolog (C. elegans) |
| chr5_+_133861339 | 5.26 |
ENST00000282605.4
ENST00000361895.2 ENST00000402835.1 |
PHF15
|
jade family PHD finger 2 |
| chr2_-_37551846 | 5.22 |
ENST00000443187.1
|
PRKD3
|
protein kinase D3 |
| chr2_+_223725723 | 5.15 |
ENST00000535678.1
|
ACSL3
|
acyl-CoA synthetase long-chain family member 3 |
| chr17_+_47075023 | 5.14 |
ENST00000431824.2
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1 |
| chr1_-_52870104 | 5.14 |
ENST00000371568.3
|
ORC1
|
origin recognition complex, subunit 1 |
| chr15_-_82338460 | 5.09 |
ENST00000558133.1
ENST00000329713.4 |
MEX3B
|
mex-3 RNA binding family member B |
| chr17_-_43045439 | 4.94 |
ENST00000253407.3
|
C1QL1
|
complement component 1, q subcomponent-like 1 |
| chr8_+_26435359 | 4.93 |
ENST00000311151.5
|
DPYSL2
|
dihydropyrimidinase-like 2 |
| chr4_+_129732419 | 4.90 |
ENST00000510308.1
|
PHF17
|
jade family PHD finger 1 |
| chr6_+_11537910 | 4.89 |
ENST00000543875.1
|
TMEM170B
|
transmembrane protein 170B |
| chr12_+_54393880 | 4.87 |
ENST00000303450.4
|
HOXC9
|
homeobox C9 |
| chr20_+_47662805 | 4.87 |
ENST00000262982.2
ENST00000542325.1 |
CSE1L
|
CSE1 chromosome segregation 1-like (yeast) |
| chr19_-_14247365 | 4.78 |
ENST00000592798.1
ENST00000474890.1 |
ASF1B
|
anti-silencing function 1B histone chaperone |
| chr11_-_64851496 | 4.75 |
ENST00000404147.3
ENST00000275517.3 |
CDCA5
|
cell division cycle associated 5 |
| chr19_+_14544099 | 4.71 |
ENST00000242783.6
ENST00000586557.1 ENST00000590097.1 |
PKN1
|
protein kinase N1 |
| chr1_-_52870059 | 4.61 |
ENST00000371566.1
|
ORC1
|
origin recognition complex, subunit 1 |
| chr16_-_57832004 | 4.61 |
ENST00000562503.1
|
KIFC3
|
kinesin family member C3 |
| chr9_+_130965651 | 4.59 |
ENST00000475805.1
ENST00000341179.7 ENST00000372923.3 |
DNM1
|
dynamin 1 |
| chr5_+_133861790 | 4.57 |
ENST00000395003.1
|
PHF15
|
jade family PHD finger 2 |
| chr2_-_61765732 | 4.57 |
ENST00000443240.1
ENST00000436018.1 |
XPO1
|
exportin 1 (CRM1 homolog, yeast) |
| chr17_+_43299241 | 4.57 |
ENST00000328118.3
|
FMNL1
|
formin-like 1 |
| chr12_-_90103077 | 4.56 |
ENST00000551310.1
|
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1 |
| chr15_-_77924689 | 4.55 |
ENST00000355300.6
|
LINGO1
|
leucine rich repeat and Ig domain containing 1 |
| chr9_-_96717654 | 4.55 |
ENST00000253968.6
|
BARX1
|
BARX homeobox 1 |
| chr9_-_131940526 | 4.51 |
ENST00000372491.2
|
IER5L
|
immediate early response 5-like |
| chr5_+_10564432 | 4.51 |
ENST00000296657.5
|
ANKRD33B
|
ankyrin repeat domain 33B |
| chr20_-_32274179 | 4.47 |
ENST00000343380.5
|
E2F1
|
E2F transcription factor 1 |
| chr12_+_98909520 | 4.42 |
ENST00000261210.5
|
TMPO
|
thymopoietin |
| chr3_+_110790590 | 4.33 |
ENST00000485303.1
|
PVRL3
|
poliovirus receptor-related 3 |
| chr1_+_26798955 | 4.32 |
ENST00000361427.5
|
HMGN2
|
high mobility group nucleosomal binding domain 2 |
| chr17_+_37026284 | 4.32 |
ENST00000433206.2
ENST00000435347.3 |
LASP1
|
LIM and SH3 protein 1 |
| chr5_-_172662230 | 4.32 |
ENST00000424406.2
|
NKX2-5
|
NK2 homeobox 5 |
| chr6_+_27861190 | 4.31 |
ENST00000303806.4
|
HIST1H2BO
|
histone cluster 1, H2bo |
| chr6_-_37665751 | 4.31 |
ENST00000297153.7
ENST00000434837.3 |
MDGA1
|
MAM domain containing glycosylphosphatidylinositol anchor 1 |
| chr12_-_1703331 | 4.29 |
ENST00000339235.3
|
FBXL14
|
F-box and leucine-rich repeat protein 14 |
| chr8_-_21988558 | 4.23 |
ENST00000312841.8
|
HR
|
hair growth associated |
| chr3_+_110790867 | 4.21 |
ENST00000486596.1
ENST00000493615.1 |
PVRL3
|
poliovirus receptor-related 3 |
| chr17_-_46703826 | 4.21 |
ENST00000550387.1
ENST00000311177.5 |
HOXB9
|
homeobox B9 |
| chr7_-_138666053 | 4.20 |
ENST00000440172.1
ENST00000422774.1 |
KIAA1549
|
KIAA1549 |
| chr10_+_70587279 | 4.20 |
ENST00000298596.6
ENST00000399169.4 ENST00000399165.4 ENST00000399162.2 |
STOX1
|
storkhead box 1 |
| chr1_-_245026388 | 4.18 |
ENST00000440865.1
|
HNRNPU
|
heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) |
| chr1_+_157963063 | 4.14 |
ENST00000360089.4
ENST00000368173.3 ENST00000392272.2 |
KIRREL
|
kin of IRRE like (Drosophila) |
| chr16_+_46723552 | 4.12 |
ENST00000219097.2
ENST00000568364.2 |
ORC6
|
origin recognition complex, subunit 6 |
| chr7_+_150756657 | 4.08 |
ENST00000413384.2
|
SLC4A2
|
solute carrier family 4 (anion exchanger), member 2 |
| chr12_+_98909260 | 4.05 |
ENST00000556029.1
|
TMPO
|
thymopoietin |
| chr5_-_172662197 | 4.05 |
ENST00000521848.1
|
NKX2-5
|
NK2 homeobox 5 |
| chr9_+_130965677 | 4.03 |
ENST00000393594.3
ENST00000486160.1 |
DNM1
|
dynamin 1 |
| chr1_+_212208919 | 4.01 |
ENST00000366991.4
ENST00000542077.1 |
DTL
|
denticleless E3 ubiquitin protein ligase homolog (Drosophila) |
| chr2_+_172778952 | 4.00 |
ENST00000392584.1
ENST00000264108.4 |
HAT1
|
histone acetyltransferase 1 |
| chr16_-_57831676 | 3.99 |
ENST00000465878.2
ENST00000539578.1 ENST00000561524.1 |
KIFC3
|
kinesin family member C3 |
| chr10_-_98347063 | 3.99 |
ENST00000443638.1
|
TM9SF3
|
transmembrane 9 superfamily member 3 |
| chr7_-_27239703 | 3.96 |
ENST00000222753.4
|
HOXA13
|
homeobox A13 |
| chr10_+_14920843 | 3.95 |
ENST00000433779.1
ENST00000378325.3 ENST00000354919.6 ENST00000313519.5 ENST00000420416.1 |
SUV39H2
|
suppressor of variegation 3-9 homolog 2 (Drosophila) |
| chrX_-_16888448 | 3.95 |
ENST00000468092.1
ENST00000404022.1 ENST00000380087.2 |
RBBP7
|
retinoblastoma binding protein 7 |
| chr1_+_154297988 | 3.93 |
ENST00000368487.3
|
ATP8B2
|
ATPase, aminophospholipid transporter, class I, type 8B, member 2 |
| chr15_+_99645277 | 3.93 |
ENST00000336292.6
ENST00000328642.7 |
SYNM
|
synemin, intermediate filament protein |
| chr2_+_74212073 | 3.91 |
ENST00000441217.1
|
AC073046.25
|
AC073046.25 |
| chr9_+_137967268 | 3.86 |
ENST00000371799.4
ENST00000277415.11 |
OLFM1
|
olfactomedin 1 |
| chr19_-_10341948 | 3.76 |
ENST00000590320.1
ENST00000592342.1 ENST00000588952.1 |
S1PR2
DNMT1
|
sphingosine-1-phosphate receptor 2 DNA (cytosine-5-)-methyltransferase 1 |
| chr4_+_128802016 | 3.76 |
ENST00000270861.5
ENST00000515069.1 ENST00000513090.1 ENST00000507249.1 |
PLK4
|
polo-like kinase 4 |
| chr10_+_92980517 | 3.75 |
ENST00000336126.5
|
PCGF5
|
polycomb group ring finger 5 |
| chr11_-_6440283 | 3.74 |
ENST00000299402.6
ENST00000609360.1 ENST00000389906.2 ENST00000532020.2 |
APBB1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
| chr17_-_26926005 | 3.73 |
ENST00000536674.2
|
SPAG5
|
sperm associated antigen 5 |
| chr4_-_174255400 | 3.72 |
ENST00000506267.1
|
HMGB2
|
high mobility group box 2 |
| chr9_+_137967366 | 3.70 |
ENST00000252854.4
|
OLFM1
|
olfactomedin 1 |
| chr2_+_121493717 | 3.69 |
ENST00000418323.1
|
GLI2
|
GLI family zinc finger 2 |
| chr17_+_43299156 | 3.69 |
ENST00000331495.3
|
FMNL1
|
formin-like 1 |
| chr9_+_36572851 | 3.67 |
ENST00000298048.2
ENST00000538311.1 ENST00000536987.1 ENST00000545008.1 ENST00000536860.1 ENST00000536329.1 ENST00000541717.1 ENST00000543751.1 |
MELK
|
maternal embryonic leucine zipper kinase |
| chr19_+_34287751 | 3.65 |
ENST00000590771.1
ENST00000589786.1 ENST00000284006.6 ENST00000588881.1 |
KCTD15
|
potassium channel tetramerization domain containing 15 |
| chr3_-_15901278 | 3.62 |
ENST00000399451.2
|
ANKRD28
|
ankyrin repeat domain 28 |
| chr3_+_14444063 | 3.61 |
ENST00000454876.2
ENST00000360861.3 ENST00000416216.2 |
SLC6A6
|
solute carrier family 6 (neurotransmitter transporter), member 6 |
| chr12_-_123717643 | 3.61 |
ENST00000541437.1
ENST00000606320.1 |
MPHOSPH9
|
M-phase phosphoprotein 9 |
| chrX_-_54209640 | 3.61 |
ENST00000375180.2
ENST00000328235.4 ENST00000477084.1 |
FAM120C
|
family with sequence similarity 120C |
| chr10_+_60272814 | 3.60 |
ENST00000373886.3
|
BICC1
|
bicaudal C homolog 1 (Drosophila) |
| chr8_-_120868078 | 3.60 |
ENST00000313655.4
|
DSCC1
|
DNA replication and sister chromatid cohesion 1 |
| chr16_-_87903079 | 3.60 |
ENST00000261622.4
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
| chr3_+_49507674 | 3.60 |
ENST00000431960.1
ENST00000452317.1 ENST00000435508.2 ENST00000452060.1 ENST00000428779.1 ENST00000419218.1 ENST00000430636.1 |
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1) |
| chr15_+_69706585 | 3.59 |
ENST00000559279.1
ENST00000395392.2 |
KIF23
|
kinesin family member 23 |
| chr15_+_27112380 | 3.59 |
ENST00000554596.1
|
GABRA5
|
gamma-aminobutyric acid (GABA) A receptor, alpha 5 |
| chr3_+_110790715 | 3.59 |
ENST00000319792.3
|
PVRL3
|
poliovirus receptor-related 3 |
| chr9_+_95947198 | 3.58 |
ENST00000448039.1
ENST00000297954.4 ENST00000395477.2 ENST00000395475.2 ENST00000349097.3 ENST00000427277.2 ENST00000356055.3 ENST00000432730.1 |
WNK2
|
WNK lysine deficient protein kinase 2 |
| chr17_-_79849438 | 3.57 |
ENST00000331204.4
ENST00000505490.2 |
ALYREF
|
Aly/REF export factor |
| chr19_-_39340563 | 3.55 |
ENST00000601813.1
|
HNRNPL
|
heterogeneous nuclear ribonucleoprotein L |
| chr1_+_100818009 | 3.54 |
ENST00000370125.2
ENST00000361544.6 ENST00000370124.3 |
CDC14A
|
cell division cycle 14A |
| chr15_+_57211318 | 3.53 |
ENST00000557947.1
|
TCF12
|
transcription factor 12 |
| chr17_+_36508111 | 3.51 |
ENST00000331159.5
ENST00000577233.1 |
SOCS7
|
suppressor of cytokine signaling 7 |
| chr17_+_57232690 | 3.51 |
ENST00000262293.4
|
PRR11
|
proline rich 11 |
| chr20_+_37554955 | 3.50 |
ENST00000217429.4
|
FAM83D
|
family with sequence similarity 83, member D |
| chr5_-_59189545 | 3.49 |
ENST00000340635.6
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific |
| chr15_-_65067773 | 3.49 |
ENST00000300069.4
|
RBPMS2
|
RNA binding protein with multiple splicing 2 |
| chr12_-_58145604 | 3.47 |
ENST00000552254.1
|
CDK4
|
cyclin-dependent kinase 4 |
| chr17_+_38219063 | 3.46 |
ENST00000584985.1
ENST00000264637.4 ENST00000450525.2 |
THRA
|
thyroid hormone receptor, alpha |
| chr1_+_157963391 | 3.45 |
ENST00000359209.6
ENST00000416935.2 |
KIRREL
|
kin of IRRE like (Drosophila) |
| chrX_-_20284733 | 3.44 |
ENST00000438357.1
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
| chr15_+_44719394 | 3.43 |
ENST00000260327.4
ENST00000396780.1 |
CTDSPL2
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2 |
| chr4_+_84457529 | 3.42 |
ENST00000264409.4
|
AGPAT9
|
1-acylglycerol-3-phosphate O-acyltransferase 9 |
| chr2_+_20646824 | 3.41 |
ENST00000272233.4
|
RHOB
|
ras homolog family member B |
| chr11_+_12696102 | 3.40 |
ENST00000527636.1
ENST00000527376.1 |
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
| chr10_+_75757863 | 3.38 |
ENST00000372755.3
ENST00000211998.4 ENST00000417648.2 |
VCL
|
vinculin |
| chr15_+_50474385 | 3.38 |
ENST00000267842.5
|
SLC27A2
|
solute carrier family 27 (fatty acid transporter), member 2 |
| chrX_-_16887963 | 3.37 |
ENST00000380084.4
|
RBBP7
|
retinoblastoma binding protein 7 |
| chr11_-_126870655 | 3.36 |
ENST00000525144.2
|
KIRREL3
|
kin of IRRE like 3 (Drosophila) |
| chr14_-_64971893 | 3.35 |
ENST00000555220.1
|
ZBTB25
|
zinc finger and BTB domain containing 25 |
| chr17_-_74236382 | 3.30 |
ENST00000592271.1
ENST00000319945.6 ENST00000269391.6 |
RNF157
|
ring finger protein 157 |
| chr6_-_153304697 | 3.29 |
ENST00000367241.3
|
FBXO5
|
F-box protein 5 |
| chr12_-_6798025 | 3.29 |
ENST00000542351.1
ENST00000538829.1 |
ZNF384
|
zinc finger protein 384 |
| chr1_-_45672221 | 3.28 |
ENST00000359600.5
|
ZSWIM5
|
zinc finger, SWIM-type containing 5 |
| chr16_-_57831914 | 3.27 |
ENST00000421376.2
|
KIFC3
|
kinesin family member C3 |
| chr9_-_99180597 | 3.26 |
ENST00000375256.4
|
ZNF367
|
zinc finger protein 367 |
| chr2_-_44223089 | 3.26 |
ENST00000447246.1
ENST00000409946.1 ENST00000409659.1 |
LRPPRC
|
leucine-rich pentatricopeptide repeat containing |
| chr4_+_84457250 | 3.25 |
ENST00000395226.2
|
AGPAT9
|
1-acylglycerol-3-phosphate O-acyltransferase 9 |
| chr11_-_126870683 | 3.24 |
ENST00000525704.2
|
KIRREL3
|
kin of IRRE like 3 (Drosophila) |
| chr14_+_32546145 | 3.23 |
ENST00000556611.1
ENST00000539826.2 |
ARHGAP5
|
Rho GTPase activating protein 5 |
| chr8_-_142318398 | 3.21 |
ENST00000520137.1
|
SLC45A4
|
solute carrier family 45, member 4 |
| chr2_+_153574428 | 3.20 |
ENST00000326446.5
|
ARL6IP6
|
ADP-ribosylation-like factor 6 interacting protein 6 |
| chr4_+_129732467 | 3.19 |
ENST00000413543.2
|
PHF17
|
jade family PHD finger 1 |
| chr12_+_53662073 | 3.18 |
ENST00000553219.1
ENST00000257934.4 |
ESPL1
|
extra spindle pole bodies homolog 1 (S. cerevisiae) |
| chr9_-_86322516 | 3.16 |
ENST00000529923.1
|
UBQLN1
|
ubiquilin 1 |
| chr17_-_78450398 | 3.16 |
ENST00000306773.4
|
NPTX1
|
neuronal pentraxin I |
| chr11_+_8102846 | 3.15 |
ENST00000299506.2
|
TUB
|
tubby bipartite transcription factor |
| chr2_+_175199674 | 3.10 |
ENST00000394967.2
|
SP9
|
Sp9 transcription factor |
| chr2_+_206547215 | 3.10 |
ENST00000360409.3
ENST00000540178.1 ENST00000540841.1 ENST00000355117.4 ENST00000450507.1 ENST00000417189.1 |
NRP2
|
neuropilin 2 |
| chr17_+_37026106 | 3.09 |
ENST00000318008.6
|
LASP1
|
LIM and SH3 protein 1 |
| chr20_+_306177 | 3.07 |
ENST00000544632.1
|
SOX12
|
SRY (sex determining region Y)-box 12 |
| chr1_-_244013384 | 3.06 |
ENST00000366539.1
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3 |
| chr2_+_32288725 | 3.05 |
ENST00000315285.3
|
SPAST
|
spastin |
| chr19_+_35521572 | 3.05 |
ENST00000262631.5
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
| chrX_+_24711997 | 3.04 |
ENST00000379068.3
ENST00000379059.3 |
POLA1
|
polymerase (DNA directed), alpha 1, catalytic subunit |
| chr17_+_57233087 | 3.04 |
ENST00000578777.1
ENST00000577457.1 ENST00000582995.1 |
PRR11
|
proline rich 11 |
| chr9_-_34523027 | 3.03 |
ENST00000399775.2
|
ENHO
|
energy homeostasis associated |
| chr2_+_42396472 | 3.02 |
ENST00000318522.5
ENST00000402711.2 |
EML4
|
echinoderm microtubule associated protein like 4 |
| chr2_+_37571717 | 3.02 |
ENST00000338415.3
ENST00000404976.1 |
QPCT
|
glutaminyl-peptide cyclotransferase |
| chr16_+_11439286 | 3.01 |
ENST00000312499.5
ENST00000576027.1 |
RMI2
|
RecQ mediated genome instability 2 |
| chr12_-_12419905 | 3.01 |
ENST00000535731.1
|
LRP6
|
low density lipoprotein receptor-related protein 6 |
| chr9_-_139965000 | 2.99 |
ENST00000409687.3
|
SAPCD2
|
suppressor APC domain containing 2 |
| chr15_-_57210769 | 2.99 |
ENST00000559000.1
|
ZNF280D
|
zinc finger protein 280D |
| chrX_-_70474499 | 2.99 |
ENST00000353904.2
|
ZMYM3
|
zinc finger, MYM-type 3 |
| chr10_+_17271266 | 2.98 |
ENST00000224237.5
|
VIM
|
vimentin |
| chr1_-_92351666 | 2.97 |
ENST00000465892.2
ENST00000417833.2 |
TGFBR3
|
transforming growth factor, beta receptor III |
| chr1_-_226496898 | 2.96 |
ENST00000481685.1
|
LIN9
|
lin-9 homolog (C. elegans) |
| chr6_+_7727030 | 2.96 |
ENST00000283147.6
|
BMP6
|
bone morphogenetic protein 6 |
| chr15_+_73344911 | 2.95 |
ENST00000560262.1
ENST00000558964.1 |
NEO1
|
neogenin 1 |
| chr19_+_16435625 | 2.95 |
ENST00000248071.5
ENST00000592003.1 |
KLF2
|
Kruppel-like factor 2 |
| chrX_+_49126294 | 2.94 |
ENST00000466508.1
ENST00000438316.1 ENST00000055335.6 ENST00000495799.1 |
PPP1R3F
|
protein phosphatase 1, regulatory subunit 3F |
| chr11_-_118966167 | 2.94 |
ENST00000530167.1
|
H2AFX
|
H2A histone family, member X |
| chr20_+_3777078 | 2.93 |
ENST00000340833.4
|
CDC25B
|
cell division cycle 25B |
| chr11_-_19262486 | 2.93 |
ENST00000250024.4
|
E2F8
|
E2F transcription factor 8 |
| chr17_-_53499218 | 2.92 |
ENST00000571578.1
|
MMD
|
monocyte to macrophage differentiation-associated |
| chr16_-_58034357 | 2.92 |
ENST00000562909.1
|
ZNF319
|
zinc finger protein 319 |
| chr17_+_43239231 | 2.92 |
ENST00000591576.1
ENST00000591070.1 ENST00000592695.1 |
HEXIM2
|
hexamethylene bis-acetamide inducible 2 |
| chr22_-_31742218 | 2.92 |
ENST00000266269.5
ENST00000405309.3 ENST00000351933.4 |
PATZ1
|
POZ (BTB) and AT hook containing zinc finger 1 |
| chr20_+_306221 | 2.92 |
ENST00000342665.2
|
SOX12
|
SRY (sex determining region Y)-box 12 |
| chr16_-_3030407 | 2.90 |
ENST00000431515.2
ENST00000574385.1 ENST00000576268.1 ENST00000574730.1 ENST00000575632.1 ENST00000573944.1 ENST00000262300.8 |
PKMYT1
|
protein kinase, membrane associated tyrosine/threonine 1 |
| chr14_+_32546274 | 2.90 |
ENST00000396582.2
|
ARHGAP5
|
Rho GTPase activating protein 5 |
| chr1_+_62901968 | 2.89 |
ENST00000452143.1
ENST00000442679.1 ENST00000371146.1 |
USP1
|
ubiquitin specific peptidase 1 |
| chr10_-_14646388 | 2.88 |
ENST00000468747.1
ENST00000378467.4 |
FAM107B
|
family with sequence similarity 107, member B |
| chr13_-_95953589 | 2.87 |
ENST00000538287.1
ENST00000376887.4 ENST00000412704.1 ENST00000536256.1 ENST00000431522.1 |
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
| chr12_-_56843161 | 2.85 |
ENST00000554616.1
ENST00000553532.1 ENST00000229201.4 |
TIMELESS
|
timeless circadian clock |
| chr3_-_120068143 | 2.85 |
ENST00000295628.3
|
LRRC58
|
leucine rich repeat containing 58 |
| chr19_+_36545833 | 2.84 |
ENST00000401500.2
ENST00000270301.7 ENST00000427823.2 |
WDR62
|
WD repeat domain 62 |
| chr6_-_85474219 | 2.84 |
ENST00000369663.5
|
TBX18
|
T-box 18 |
| chr17_-_42296855 | 2.84 |
ENST00000436088.1
|
UBTF
|
upstream binding transcription factor, RNA polymerase I |
| chr13_+_35516390 | 2.84 |
ENST00000540320.1
ENST00000400445.3 ENST00000310336.4 |
NBEA
|
neurobeachin |
| chr11_+_12695944 | 2.84 |
ENST00000361905.4
|
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
| chr15_+_50474412 | 2.84 |
ENST00000380902.4
|
SLC27A2
|
solute carrier family 27 (fatty acid transporter), member 2 |
| chr1_+_94884023 | 2.84 |
ENST00000315713.5
|
ABCD3
|
ATP-binding cassette, sub-family D (ALD), member 3 |
| chr7_-_73184588 | 2.82 |
ENST00000395145.2
|
CLDN3
|
claudin 3 |
| chr6_+_26104104 | 2.81 |
ENST00000377803.2
|
HIST1H4C
|
histone cluster 1, H4c |
| chr4_-_6474173 | 2.81 |
ENST00000382599.4
|
PPP2R2C
|
protein phosphatase 2, regulatory subunit B, gamma |
Network of associatons between targets according to the STRING database.
First level regulatory network of TFDP1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.8 | 14.4 | GO:0060929 | Purkinje myocyte differentiation(GO:0003168) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
| 3.3 | 10.0 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 3.0 | 3.0 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 2.6 | 10.5 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
| 2.4 | 4.8 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 2.2 | 4.5 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 2.2 | 6.6 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
| 2.1 | 6.4 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 2.0 | 6.0 | GO:1903465 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 1.9 | 5.8 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 1.9 | 19.3 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 1.8 | 5.4 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 1.7 | 6.9 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 1.7 | 6.7 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 1.7 | 8.3 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 1.6 | 6.6 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 1.6 | 4.9 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
| 1.6 | 6.6 | GO:0006272 | leading strand elongation(GO:0006272) |
| 1.6 | 4.9 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 1.6 | 4.8 | GO:0070632 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 1.6 | 4.8 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 1.6 | 6.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
| 1.5 | 9.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 1.5 | 17.6 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
| 1.4 | 4.2 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 1.4 | 2.8 | GO:0002076 | osteoblast development(GO:0002076) |
| 1.4 | 8.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 1.4 | 5.5 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 1.2 | 4.9 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 1.2 | 6.0 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
| 1.2 | 4.7 | GO:0016598 | protein arginylation(GO:0016598) |
| 1.2 | 3.5 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 1.2 | 3.5 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
| 1.1 | 11.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 1.1 | 12.2 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 1.1 | 3.3 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 1.1 | 4.3 | GO:2000176 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 1.1 | 4.3 | GO:0061289 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 1.1 | 3.2 | GO:1901340 | negative regulation of store-operated calcium channel activity(GO:1901340) |
| 1.0 | 3.0 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 1.0 | 5.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 1.0 | 5.0 | GO:0015862 | uridine transport(GO:0015862) |
| 1.0 | 2.0 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
| 1.0 | 3.9 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 1.0 | 10.8 | GO:0007144 | female meiosis I(GO:0007144) |
| 1.0 | 1.0 | GO:0090212 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.9 | 2.8 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 0.9 | 3.8 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.9 | 2.8 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.9 | 2.8 | GO:1901207 | regulation of heart looping(GO:1901207) |
| 0.9 | 7.4 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.9 | 2.8 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.9 | 6.4 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.9 | 2.7 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.9 | 5.4 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.9 | 2.7 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.9 | 6.9 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.9 | 3.4 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.8 | 2.4 | GO:0031247 | actin rod assembly(GO:0031247) |
| 0.8 | 2.4 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.8 | 3.2 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 0.8 | 5.6 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.8 | 2.4 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
| 0.8 | 2.4 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.8 | 8.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.8 | 3.0 | GO:0036292 | DNA rewinding(GO:0036292) |
| 0.7 | 2.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.7 | 8.1 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
| 0.7 | 2.2 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
| 0.7 | 7.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.7 | 6.5 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.7 | 3.6 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 0.7 | 6.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.7 | 5.0 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.7 | 15.9 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.7 | 2.1 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.7 | 2.7 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 0.7 | 2.1 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.7 | 8.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.7 | 0.7 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.7 | 2.0 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.7 | 7.9 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.6 | 3.2 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.6 | 3.2 | GO:1905075 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 0.6 | 7.1 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.6 | 3.2 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.6 | 0.6 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.6 | 7.0 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.6 | 4.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.6 | 1.9 | GO:1903217 | regulation of protein processing involved in protein targeting to mitochondrion(GO:1903216) negative regulation of protein processing involved in protein targeting to mitochondrion(GO:1903217) |
| 0.6 | 2.5 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.6 | 1.8 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.6 | 1.8 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 0.6 | 4.2 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
| 0.6 | 1.8 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.6 | 8.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.6 | 3.0 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 0.6 | 4.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.6 | 2.3 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.6 | 0.6 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
| 0.6 | 1.2 | GO:0003285 | septum secundum development(GO:0003285) |
| 0.6 | 1.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.6 | 2.2 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
| 0.5 | 2.7 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.5 | 3.7 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.5 | 7.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
| 0.5 | 31.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.5 | 1.0 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.5 | 1.5 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.5 | 2.0 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
| 0.5 | 2.0 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.5 | 1.5 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.5 | 2.5 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.5 | 0.5 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.5 | 1.5 | GO:1901536 | negative regulation of DNA demethylation(GO:1901536) |
| 0.5 | 3.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.5 | 2.4 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.5 | 1.9 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.5 | 1.9 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.5 | 2.4 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.5 | 1.4 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.5 | 6.1 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.5 | 1.9 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.5 | 1.4 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.5 | 2.3 | GO:1900157 | negative regulation of osteoclast proliferation(GO:0090291) regulation of bone mineralization involved in bone maturation(GO:1900157) |
| 0.5 | 7.3 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.5 | 6.9 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.5 | 1.4 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.4 | 3.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.4 | 1.3 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.4 | 2.2 | GO:0061312 | BMP signaling pathway involved in heart development(GO:0061312) |
| 0.4 | 0.4 | GO:0003162 | atrioventricular node development(GO:0003162) cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
| 0.4 | 1.3 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.4 | 1.7 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.4 | 5.2 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
| 0.4 | 2.1 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 0.4 | 2.5 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.4 | 1.7 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.4 | 0.4 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.4 | 1.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.4 | 1.2 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 0.4 | 1.6 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 0.4 | 1.2 | GO:1904875 | regulation of DNA ligase activity(GO:1904875) |
| 0.4 | 3.6 | GO:0060318 | regulation of definitive erythrocyte differentiation(GO:0010724) definitive erythrocyte differentiation(GO:0060318) |
| 0.4 | 4.3 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.4 | 0.8 | GO:0009648 | photoperiodism(GO:0009648) entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.4 | 7.4 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.4 | 0.4 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 0.4 | 1.2 | GO:0045083 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
| 0.4 | 5.8 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.4 | 4.6 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.4 | 2.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.4 | 3.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.4 | 3.0 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.4 | 0.8 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
| 0.4 | 1.5 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.4 | 3.4 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.4 | 2.6 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.4 | 1.1 | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
| 0.4 | 4.8 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.4 | 2.2 | GO:0001555 | oocyte growth(GO:0001555) |
| 0.4 | 1.1 | GO:2000576 | regulation of microtubule motor activity(GO:2000574) positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.4 | 1.1 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.4 | 1.8 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.4 | 1.4 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.4 | 3.2 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.4 | 0.7 | GO:0035989 | tendon development(GO:0035989) |
| 0.4 | 1.4 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 0.4 | 1.4 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.4 | 1.4 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.3 | 3.5 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.3 | 1.4 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
| 0.3 | 2.7 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 0.3 | 1.0 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
| 0.3 | 1.0 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.3 | 1.0 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.3 | 3.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.3 | 2.0 | GO:0050893 | sensory processing(GO:0050893) |
| 0.3 | 10.2 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.3 | 4.2 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 0.3 | 3.9 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.3 | 2.6 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
| 0.3 | 1.9 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
| 0.3 | 0.6 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.3 | 1.9 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 0.3 | 0.6 | GO:0043634 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.3 | 7.6 | GO:0033197 | response to vitamin E(GO:0033197) |
| 0.3 | 1.9 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.3 | 1.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.3 | 0.6 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.3 | 3.7 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
| 0.3 | 2.2 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.3 | 10.2 | GO:0045332 | phospholipid translocation(GO:0045332) |
| 0.3 | 4.0 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
| 0.3 | 2.8 | GO:0097068 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
| 0.3 | 1.2 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 0.3 | 7.3 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.3 | 0.9 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) DNA demethylation of male pronucleus(GO:0044727) |
| 0.3 | 2.7 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.3 | 0.9 | GO:1902824 | positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.3 | 0.9 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.3 | 1.2 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 0.3 | 3.2 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.3 | 4.7 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.3 | 1.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.3 | 2.0 | GO:1902739 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.3 | 2.6 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.3 | 0.9 | GO:0015882 | L-ascorbic acid transport(GO:0015882) molecular hydrogen transport(GO:0015993) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.3 | 1.2 | GO:0035669 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.3 | 2.9 | GO:0032310 | prostaglandin secretion(GO:0032310) |
| 0.3 | 1.7 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.3 | 4.0 | GO:0060073 | micturition(GO:0060073) smooth muscle contraction involved in micturition(GO:0060083) |
| 0.3 | 1.1 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 0.3 | 0.6 | GO:0060061 | Spemann organizer formation(GO:0060061) |
| 0.3 | 1.1 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) |
| 0.3 | 0.8 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.3 | 2.0 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.3 | 0.6 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
| 0.3 | 1.4 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.3 | 0.8 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 0.3 | 0.8 | GO:0042779 | tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.3 | 0.3 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.3 | 0.8 | GO:0042245 | RNA repair(GO:0042245) |
| 0.3 | 1.8 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.3 | 0.8 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.3 | 5.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.3 | 3.9 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.3 | 1.5 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.3 | 0.8 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.3 | 3.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.3 | 1.5 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.3 | 1.0 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.3 | 2.8 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 0.2 | 0.7 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.2 | 3.7 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.2 | 1.0 | GO:0002182 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.2 | 1.5 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.2 | 1.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.2 | 1.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 0.2 | 1.5 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.2 | 1.2 | GO:0031291 | mitotic chromosome movement towards spindle pole(GO:0007079) Ran protein signal transduction(GO:0031291) |
| 0.2 | 3.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.2 | 0.7 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
| 0.2 | 3.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.2 | 1.0 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.2 | 3.6 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.2 | 2.4 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.2 | 5.9 | GO:0016075 | rRNA catabolic process(GO:0016075) |
| 0.2 | 1.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.2 | 2.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.2 | 1.4 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.2 | 1.6 | GO:0001878 | response to yeast(GO:0001878) |
| 0.2 | 1.8 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.2 | 1.1 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.2 | 2.7 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.2 | 0.2 | GO:0072708 | response to sorbitol(GO:0072708) |
| 0.2 | 0.4 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.2 | 2.2 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.2 | 10.3 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.2 | 1.1 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
| 0.2 | 3.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.2 | 2.1 | GO:0042426 | choline catabolic process(GO:0042426) |
| 0.2 | 0.8 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 0.2 | 2.5 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
| 0.2 | 5.6 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.2 | 3.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.2 | 2.0 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
| 0.2 | 2.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.2 | 0.8 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.2 | 4.6 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.2 | 1.4 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.2 | 1.8 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.2 | 2.7 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.2 | 2.1 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
| 0.2 | 1.0 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.2 | 4.6 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.2 | 1.0 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.2 | 1.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.2 | 2.5 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.2 | 4.4 | GO:0006266 | DNA ligation(GO:0006266) |
| 0.2 | 2.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.2 | 0.4 | GO:0032886 | regulation of microtubule-based process(GO:0032886) |
| 0.2 | 1.1 | GO:0071543 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.2 | 2.3 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.2 | 5.0 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.2 | 1.3 | GO:1903288 | positive regulation of calcium:sodium antiporter activity(GO:1903281) positive regulation of potassium ion import(GO:1903288) |
| 0.2 | 0.6 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
| 0.2 | 1.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.2 | 1.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.2 | 0.7 | GO:0014870 | response to muscle inactivity(GO:0014870) |
| 0.2 | 0.9 | GO:2001076 | thorax and anterior abdomen determination(GO:0007356) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 0.2 | 0.4 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.2 | 5.4 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 0.2 | 2.7 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.2 | 1.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.2 | 0.5 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.2 | 0.5 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.2 | 0.5 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
| 0.2 | 0.5 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.2 | 0.7 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.2 | 0.7 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.2 | 2.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.2 | 1.9 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.2 | 0.8 | GO:0035803 | egg coat formation(GO:0035803) |
| 0.2 | 3.0 | GO:0000732 | strand displacement(GO:0000732) |
| 0.2 | 1.5 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 0.2 | 1.7 | GO:0007498 | mesoderm development(GO:0007498) |
| 0.2 | 0.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.2 | 5.3 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
| 0.2 | 0.5 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.2 | 0.7 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) |
| 0.2 | 1.8 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.2 | 0.7 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.2 | 1.0 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.2 | 9.2 | GO:0043486 | histone exchange(GO:0043486) |
| 0.2 | 0.7 | GO:1990868 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
| 0.2 | 2.5 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.2 | 0.8 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 0.2 | 1.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.2 | 0.8 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
| 0.2 | 1.5 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
| 0.2 | 0.6 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
| 0.2 | 0.8 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.2 | 1.6 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.2 | 2.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
| 0.2 | 4.8 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.2 | 2.6 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
| 0.2 | 0.3 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.2 | 0.6 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
| 0.2 | 5.7 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.2 | 0.5 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.2 | 0.3 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.2 | 0.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.2 | 0.6 | GO:0021769 | orbitofrontal cortex development(GO:0021769) |
| 0.1 | 0.6 | GO:0019605 | butyrate metabolic process(GO:0019605) |
| 0.1 | 0.6 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.1 | 0.9 | GO:0018032 | protein amidation(GO:0018032) |
| 0.1 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.1 | 1.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 | 1.8 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.1 | 1.6 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.1 | 1.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.1 | 0.7 | GO:0030222 | eosinophil differentiation(GO:0030222) |
| 0.1 | 4.8 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.1 | 1.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 | 1.4 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.1 | 2.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.1 | 0.7 | GO:0036115 | fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.1 | 4.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.1 | 1.4 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.1 | 1.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.1 | 1.7 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.1 | 0.4 | GO:0009080 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.1 | 0.6 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
| 0.1 | 6.7 | GO:0048536 | spleen development(GO:0048536) |
| 0.1 | 0.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.1 | 6.0 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.1 | 0.3 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 0.1 | 0.5 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.1 | 1.8 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.1 | 1.3 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.1 | 4.4 | GO:0019835 | cytolysis(GO:0019835) |
| 0.1 | 2.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 0.3 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
| 0.1 | 1.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
| 0.1 | 2.6 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.1 | 0.5 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
| 0.1 | 2.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.1 | 0.5 | GO:0019322 | xylulose metabolic process(GO:0005997) pentose biosynthetic process(GO:0019322) glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.1 | 0.9 | GO:1904550 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.1 | 1.4 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.1 | 0.1 | GO:0044793 | negative regulation by host of viral process(GO:0044793) negative regulation by host of viral genome replication(GO:0044828) |
| 0.1 | 1.5 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
| 0.1 | 2.0 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.1 | 2.4 | GO:0050900 | leukocyte migration(GO:0050900) |
| 0.1 | 1.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.1 | 1.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.1 | 0.4 | GO:0090108 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 0.1 | 1.5 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.1 | 0.2 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 0.1 | 2.1 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
| 0.1 | 0.2 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
| 0.1 | 1.6 | GO:0046476 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) glycosylceramide biosynthetic process(GO:0046476) |
| 0.1 | 0.4 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.1 | 1.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.1 | 1.2 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
| 0.1 | 0.5 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.1 | 1.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
| 0.1 | 0.5 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 | 0.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 | 1.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.1 | 2.1 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
| 0.1 | 1.3 | GO:0043587 | tongue morphogenesis(GO:0043587) |
| 0.1 | 2.5 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
| 0.1 | 1.6 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.1 | 1.9 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.1 | 2.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 | 0.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.1 | 0.2 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.1 | 1.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.1 | 0.7 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.1 | 11.2 | GO:0051225 | spindle assembly(GO:0051225) |
| 0.1 | 0.4 | GO:0061525 | hindgut development(GO:0061525) |
| 0.1 | 1.4 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.1 | 0.4 | GO:0019695 | choline metabolic process(GO:0019695) |
| 0.1 | 1.6 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 | 4.1 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
| 0.1 | 9.0 | GO:0007588 | excretion(GO:0007588) |
| 0.1 | 3.0 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.1 | 0.4 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
| 0.1 | 0.1 | GO:0060168 | regulation of adenosine receptor signaling pathway(GO:0060167) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.1 | 0.3 | GO:0080120 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.1 | 0.4 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.1 | 1.4 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
| 0.1 | 0.6 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.1 | 0.8 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 | 1.5 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.1 | 2.6 | GO:0038084 | vascular endothelial growth factor signaling pathway(GO:0038084) |
| 0.1 | 0.6 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.1 | 1.3 | GO:0042177 | negative regulation of protein catabolic process(GO:0042177) |
| 0.1 | 1.0 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 | 0.5 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.1 | 1.5 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 | 1.8 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 | 0.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 | 0.8 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.1 | 2.0 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 | 0.2 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
| 0.1 | 0.2 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.1 | 1.3 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.1 | 1.5 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 0.1 | 0.6 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.1 | 0.2 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
| 0.1 | 2.0 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.1 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.1 | 2.7 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 | 1.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.1 | 0.9 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.1 | 1.3 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
| 0.1 | 3.6 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.1 | 0.4 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
| 0.1 | 0.8 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
| 0.1 | 2.9 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.1 | 1.8 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
| 0.1 | 0.3 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.1 | 0.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 | 0.6 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
| 0.1 | 1.4 | GO:0006814 | sodium ion transport(GO:0006814) |
| 0.1 | 1.0 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
| 0.1 | 3.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 | 0.9 | GO:0071383 | cellular response to steroid hormone stimulus(GO:0071383) |
| 0.1 | 0.6 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.1 | 0.6 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 | 0.4 | GO:0007320 | insemination(GO:0007320) |
| 0.1 | 0.3 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
| 0.1 | 0.3 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.1 | 0.5 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 | 0.5 | GO:1900077 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.1 | 0.4 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.1 | 0.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.1 | 0.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.1 | 1.0 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.1 | 0.7 | GO:0030242 | pexophagy(GO:0030242) |
| 0.1 | 0.8 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 | 0.6 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.1 | 4.3 | GO:0090003 | regulation of establishment of protein localization to plasma membrane(GO:0090003) |
| 0.1 | 0.7 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.1 | 0.2 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.1 | 1.7 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 | 0.2 | GO:0070781 | response to biotin(GO:0070781) |
| 0.1 | 1.3 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.1 | 1.6 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.1 | 3.2 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 | 1.1 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
| 0.1 | 1.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 | 0.7 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.1 | 0.8 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.1 | 0.7 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
| 0.1 | 1.0 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.1 | 2.1 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.1 | 0.5 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.1 | 1.9 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 2.2 | GO:0014904 | myotube cell development(GO:0014904) |
| 0.1 | 1.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.1 | 0.7 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.1 | 1.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 | 0.8 | GO:0010155 | regulation of proton transport(GO:0010155) |
| 0.1 | 1.4 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.1 | 1.0 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.1 | 0.7 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.1 | 0.7 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.1 | 0.1 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.1 | 1.6 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.1 | 0.5 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.1 | 1.1 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.1 | 1.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.1 | 0.7 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.1 | 5.1 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
| 0.1 | 1.3 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 0.1 | 1.3 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.1 | 0.6 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.1 | 0.5 | GO:0031929 | TOR signaling(GO:0031929) |
| 0.1 | 0.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 | 0.3 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.1 | 0.9 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 | 2.1 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.1 | 0.9 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.1 | 1.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.1 | 0.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.1 | 0.5 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 | 1.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.1 | 0.5 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.1 | 0.8 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
| 0.1 | 0.2 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.1 | 0.2 | GO:0006424 | glutamyl-tRNA aminoacylation(GO:0006424) |
| 0.1 | 0.6 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
| 0.1 | 0.3 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.1 | 0.9 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.1 | 0.7 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
| 0.1 | 1.6 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.1 | 0.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.1 | 0.5 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) |
| 0.1 | 1.1 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.1 | 0.4 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 | 1.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.1 | 1.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.1 | 1.1 | GO:0010822 | positive regulation of mitochondrion organization(GO:0010822) |
| 0.1 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 0.1 | 1.5 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
| 0.1 | 0.2 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.1 | 3.1 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.1 | 0.8 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.1 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 | 0.4 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 | 1.5 | GO:0031167 | rRNA methylation(GO:0031167) |
| 0.1 | 0.2 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.1 | 1.9 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.1 | 2.9 | GO:0072348 | sulfur compound transport(GO:0072348) |
| 0.1 | 0.7 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.1 | 0.6 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.1 | 0.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 | 0.9 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 | 0.9 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
| 0.1 | 1.0 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.1 | 1.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
| 0.1 | 1.3 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.1 | 2.0 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.1 | 0.5 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
| 0.1 | 0.5 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.1 | 0.7 | GO:0036258 | multivesicular body assembly(GO:0036258) |
| 0.1 | 1.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
| 0.1 | 0.8 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.1 | 0.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.1 | 0.3 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.1 | 0.3 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.1 | 0.8 | GO:0043586 | tongue development(GO:0043586) |
| 0.0 | 3.1 | GO:0014902 | myotube differentiation(GO:0014902) |
| 0.0 | 0.3 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.0 | 2.0 | GO:0006611 | protein export from nucleus(GO:0006611) |
| 0.0 | 1.1 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) |
| 0.0 | 0.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.0 | 1.0 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.0 | 0.6 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.0 | 0.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.0 | 0.4 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.0 | 0.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.0 | 1.0 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
| 0.0 | 0.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 | 0.3 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.0 | 0.0 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.0 | 3.6 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.0 | 0.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.0 | 0.6 | GO:0046777 | protein autophosphorylation(GO:0046777) |
| 0.0 | 0.5 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.0 | 3.5 | GO:0009060 | aerobic respiration(GO:0009060) |
| 0.0 | 0.8 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.0 | 0.6 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
| 0.0 | 0.6 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.0 | 1.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 | 0.2 | GO:0000154 | rRNA modification(GO:0000154) |
| 0.0 | 0.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 | 1.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.0 | 1.6 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.0 | 0.4 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.0 | 0.0 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.0 | 1.5 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.0 | 0.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.0 | 1.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
| 0.0 | 0.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.0 | 0.1 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.0 | 0.7 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 0.0 | 0.9 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 | 0.4 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.0 | 0.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 | 0.6 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 | 0.4 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.0 | 0.7 | GO:0007097 | nuclear migration(GO:0007097) |
| 0.0 | 0.3 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.0 | 0.8 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 | 1.6 | GO:0034766 | negative regulation of ion transmembrane transport(GO:0034766) |
| 0.0 | 0.8 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.0 | 0.1 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
| 0.0 | 0.0 | GO:0021897 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 0.0 | 3.0 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
| 0.0 | 1.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 0.0 | 1.7 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.0 | 3.7 | GO:0030879 | mammary gland development(GO:0030879) |
| 0.0 | 0.7 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
| 0.0 | 0.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.0 | 0.1 | GO:0048665 | neuron fate specification(GO:0048665) |
| 0.0 | 0.5 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.0 | 0.2 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.0 | 0.7 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
| 0.0 | 0.6 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
| 0.0 | 0.9 | GO:0000717 | nucleotide-excision repair, DNA duplex unwinding(GO:0000717) |
| 0.0 | 0.6 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
| 0.0 | 0.7 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.0 | 0.3 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
| 0.0 | 0.6 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 | 0.4 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.0 | 1.3 | GO:0032259 | methylation(GO:0032259) |
| 0.0 | 0.6 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.0 | 0.4 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
| 0.0 | 0.1 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
| 0.0 | 0.4 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.0 | 0.9 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.0 | 1.0 | GO:0046710 | GDP metabolic process(GO:0046710) |
| 0.0 | 0.2 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
| 0.0 | 0.2 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.0 | 0.6 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
| 0.0 | 2.7 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 | 0.4 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.0 | 0.6 | GO:0022038 | corpus callosum development(GO:0022038) |
| 0.0 | 1.0 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
| 0.0 | 0.9 | GO:0019985 | translesion synthesis(GO:0019985) |
| 0.0 | 0.4 | GO:0006309 | DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
| 0.0 | 0.1 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.0 | 0.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.0 | 1.0 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.0 | 0.2 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.0 | 0.6 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
| 0.0 | 1.4 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.0 | 4.8 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 | 0.5 | GO:0051262 | protein tetramerization(GO:0051262) |
| 0.0 | 0.5 | GO:0015698 | inorganic anion transport(GO:0015698) |
| 0.0 | 0.4 | GO:0003170 | heart valve development(GO:0003170) |
| 0.0 | 1.2 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 | 1.9 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
| 0.0 | 1.3 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
| 0.0 | 0.1 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.0 | 0.1 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
| 0.0 | 0.3 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 0.0 | 0.7 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 | 0.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.0 | 0.7 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
| 0.0 | 0.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
| 0.0 | 0.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 | 0.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 | 0.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.0 | 0.1 | GO:1904616 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
| 0.0 | 0.2 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
| 0.0 | 0.1 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
| 0.0 | 0.3 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.0 | 0.2 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.0 | 0.3 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
| 0.0 | 0.6 | GO:0007140 | male meiosis(GO:0007140) |
| 0.0 | 0.3 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.0 | 0.1 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
| 0.0 | 1.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
| 0.0 | 0.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.0 | 0.5 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
| 0.0 | 0.1 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
| 0.0 | 0.2 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
| 0.0 | 1.3 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
| 0.0 | 0.3 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.0 | 0.3 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.0 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
| 0.0 | 0.0 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.0 | 0.2 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
| 0.0 | 0.1 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.0 | 0.4 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.0 | 0.4 | GO:0006536 | glutamate metabolic process(GO:0006536) |
| 0.0 | 0.2 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.0 | 0.9 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.0 | 3.0 | GO:0016072 | rRNA processing(GO:0006364) rRNA metabolic process(GO:0016072) |
| 0.0 | 0.2 | GO:0097421 | liver regeneration(GO:0097421) |
| 0.0 | 0.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.0 | 0.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.0 | 0.1 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
| 0.0 | 0.1 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.0 | 0.1 | GO:1901678 | heme transport(GO:0015886) iron coordination entity transport(GO:1901678) |
| 0.0 | 0.4 | GO:0007050 | cell cycle arrest(GO:0007050) |
| 0.0 | 0.4 | GO:0050776 | regulation of immune response(GO:0050776) |
| 0.0 | 0.2 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 | 0.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.0 | 0.1 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
| 0.0 | 0.2 | GO:0070670 | response to interleukin-4(GO:0070670) |
| 0.0 | 0.1 | GO:0080009 | mRNA methylation(GO:0080009) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.3 | 6.8 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
| 1.6 | 4.8 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
| 1.5 | 4.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 1.2 | 4.9 | GO:0044301 | climbing fiber(GO:0044301) |
| 1.2 | 5.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 1.2 | 1.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 1.1 | 2.2 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
| 1.0 | 6.1 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 1.0 | 5.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 1.0 | 3.0 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
| 0.9 | 14.9 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.9 | 6.5 | GO:0098536 | deuterosome(GO:0098536) |
| 0.9 | 2.6 | GO:0035101 | FACT complex(GO:0035101) |
| 0.9 | 2.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.8 | 2.5 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.8 | 4.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.8 | 2.4 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.8 | 3.9 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.8 | 3.1 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.7 | 1.5 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 0.7 | 2.2 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.7 | 8.5 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.7 | 5.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.7 | 5.6 | GO:0031415 | NatA complex(GO:0031415) |
| 0.7 | 2.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.7 | 3.4 | GO:0002133 | polycystin complex(GO:0002133) |
| 0.7 | 2.6 | GO:1990423 | RZZ complex(GO:1990423) |
| 0.6 | 3.9 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.6 | 4.4 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.6 | 7.9 | GO:0000796 | condensin complex(GO:0000796) |
| 0.6 | 4.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.6 | 6.4 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 0.6 | 4.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.6 | 5.7 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.6 | 3.4 | GO:0001740 | Barr body(GO:0001740) |
| 0.6 | 6.3 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.6 | 7.9 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.5 | 7.0 | GO:0060091 | kinocilium(GO:0060091) |
| 0.5 | 7.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.5 | 9.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.5 | 7.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.5 | 1.9 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.5 | 3.8 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.5 | 2.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.5 | 1.9 | GO:0044753 | amphisome(GO:0044753) |
| 0.5 | 0.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.5 | 4.6 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.5 | 2.8 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.5 | 3.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.5 | 8.3 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.5 | 0.9 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.5 | 5.9 | GO:0042555 | MCM complex(GO:0042555) |
| 0.4 | 1.3 | GO:0032173 | septin ring(GO:0005940) septin collar(GO:0032173) |
| 0.4 | 11.2 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.4 | 8.9 | GO:0032059 | bleb(GO:0032059) |
| 0.4 | 2.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.4 | 2.2 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.4 | 1.8 | GO:0000811 | GINS complex(GO:0000811) |
| 0.4 | 1.3 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.4 | 2.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.4 | 2.7 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.4 | 1.1 | GO:0075341 | host cell PML body(GO:0075341) |
| 0.4 | 8.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.4 | 4.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.4 | 7.7 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.3 | 3.5 | GO:0005638 | lamin filament(GO:0005638) |
| 0.3 | 5.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.3 | 1.7 | GO:0071942 | XPC complex(GO:0071942) |
| 0.3 | 1.4 | GO:0031523 | Myb complex(GO:0031523) |
| 0.3 | 1.0 | GO:0044425 | membrane part(GO:0044425) |
| 0.3 | 2.0 | GO:0043596 | nuclear replication fork(GO:0043596) |
| 0.3 | 3.9 | GO:0016011 | dystroglycan complex(GO:0016011) |
| 0.3 | 13.4 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.3 | 1.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.3 | 3.6 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.3 | 1.5 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.3 | 5.5 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.3 | 5.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.3 | 1.2 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.3 | 1.7 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.3 | 11.1 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.3 | 0.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.3 | 1.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.3 | 1.1 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
| 0.3 | 1.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 0.3 | 8.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.3 | 2.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.3 | 0.8 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.3 | 4.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.3 | 3.8 | GO:0000803 | sex chromosome(GO:0000803) XY body(GO:0001741) |
| 0.2 | 4.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.2 | 5.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.2 | 0.9 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.2 | 2.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.2 | 8.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.2 | 2.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.2 | 4.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.2 | 0.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.2 | 4.3 | GO:0008091 | spectrin(GO:0008091) |
| 0.2 | 1.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.2 | 0.6 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 0.2 | 1.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
| 0.2 | 1.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.2 | 1.9 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.2 | 8.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.2 | 1.0 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.2 | 1.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.2 | 14.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.2 | 2.9 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.2 | 2.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.2 | 6.5 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.2 | 6.8 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.2 | 18.1 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.2 | 0.9 | GO:0043260 | laminin-11 complex(GO:0043260) |
| 0.2 | 0.7 | GO:1990742 | microvesicle(GO:1990742) |
| 0.2 | 0.6 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.2 | 2.6 | GO:0008278 | cohesin complex(GO:0008278) |
| 0.2 | 0.9 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.2 | 0.7 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
| 0.2 | 3.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.2 | 1.4 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.2 | 12.4 | GO:0016235 | aggresome(GO:0016235) |
| 0.2 | 1.0 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.2 | 3.0 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.2 | 0.8 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.2 | 1.3 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 0.2 | 1.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.2 | 32.6 | GO:0000922 | spindle pole(GO:0000922) |
| 0.2 | 2.5 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.2 | 1.2 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.1 | 3.6 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.1 | 3.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.1 | 1.2 | GO:0034464 | BBSome(GO:0034464) |
| 0.1 | 0.4 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
| 0.1 | 2.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.1 | 0.6 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.1 | 0.6 | GO:0031251 | PAN complex(GO:0031251) |
| 0.1 | 1.7 | GO:0072487 | MSL complex(GO:0072487) |
| 0.1 | 1.1 | GO:0043196 | varicosity(GO:0043196) |
| 0.1 | 1.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.1 | 1.0 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 2.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 3.5 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.1 | 0.9 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.1 | 1.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.1 | 7.9 | GO:0044815 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
| 0.1 | 0.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.1 | 0.9 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.1 | 1.7 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.1 | 1.3 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.1 | 1.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.1 | 2.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.1 | 0.2 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.1 | 1.2 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.1 | 1.5 | GO:0070938 | contractile ring(GO:0070938) |
| 0.1 | 0.7 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.1 | 4.9 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.1 | 4.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.1 | 0.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.1 | 1.0 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.1 | 0.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.1 | 0.6 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.1 | 0.8 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.1 | 0.9 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.1 | 2.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.1 | 0.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.1 | 0.3 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.1 | 1.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.1 | 12.9 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.1 | 1.1 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.1 | 1.9 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.1 | 7.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.1 | 2.2 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.1 | 11.8 | GO:0005901 | caveola(GO:0005901) |
| 0.1 | 0.3 | GO:0090543 | Flemming body(GO:0090543) |
| 0.1 | 9.7 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.1 | 0.5 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.1 | 2.8 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
| 0.1 | 14.1 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.1 | 0.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.1 | 1.9 | GO:0034704 | calcium channel complex(GO:0034704) |
| 0.1 | 0.2 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 0.1 | 0.7 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.1 | 0.7 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.1 | 1.3 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.1 | 1.7 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.1 | 1.3 | GO:0097346 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) INO80-type complex(GO:0097346) |
| 0.1 | 0.7 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.1 | 0.4 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.1 | 2.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.1 | 11.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.1 | 2.0 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 0.9 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.1 | 3.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 1.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.1 | 0.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.1 | 6.2 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 7.1 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.1 | 2.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 0.1 | 0.4 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.1 | 5.6 | GO:0005819 | spindle(GO:0005819) |
| 0.1 | 38.9 | GO:0005635 | nuclear envelope(GO:0005635) |
| 0.1 | 1.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.1 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 0.1 | 1.6 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.1 | 1.8 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.1 | 2.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 0.7 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.1 | 1.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 1.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.1 | 0.7 | GO:0031672 | A band(GO:0031672) |
| 0.1 | 1.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.1 | 0.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.1 | 1.1 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.1 | 1.3 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 5.2 | GO:0032153 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
| 0.1 | 0.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.1 | 0.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.1 | 1.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.1 | 1.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.1 | 0.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.1 | 9.9 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.1 | 1.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.1 | 0.8 | GO:0097433 | dense body(GO:0097433) |
| 0.1 | 1.0 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.0 | 0.6 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.0 | 17.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 0.5 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.0 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.0 | 4.3 | GO:0005814 | centriole(GO:0005814) |
| 0.0 | 3.4 | GO:0016020 | membrane(GO:0016020) |
| 0.0 | 0.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.0 | 1.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.0 | 0.5 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.0 | 4.4 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.0 | 2.5 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.0 | 5.0 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.0 | 0.4 | GO:0005675 | core TFIIH complex(GO:0000439) holo TFIIH complex(GO:0005675) |
| 0.0 | 0.3 | GO:0043034 | costamere(GO:0043034) |
| 0.0 | 1.5 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.0 | 0.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.0 | 0.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.0 | 0.9 | GO:0031105 | septin complex(GO:0031105) |
| 0.0 | 1.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.0 | 3.0 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 0.7 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.0 | 0.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.0 | 0.7 | GO:0002102 | podosome(GO:0002102) |
| 0.0 | 0.4 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.0 | 1.1 | GO:0018995 | host(GO:0018995) host cell(GO:0043657) |
| 0.0 | 0.9 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.0 | 5.2 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.0 | 0.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.0 | 0.5 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.0 | 0.8 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.0 | 2.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.0 | 1.4 | GO:0034702 | ion channel complex(GO:0034702) |
| 0.0 | 0.8 | GO:0044452 | nucleolar part(GO:0044452) |
| 0.0 | 0.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.0 | 0.2 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.0 | 1.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 0.2 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
| 0.0 | 2.0 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.0 | 3.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.0 | 3.1 | GO:0005604 | basement membrane(GO:0005604) |
| 0.0 | 0.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.0 | 0.3 | GO:0036038 | MKS complex(GO:0036038) |
| 0.0 | 0.1 | GO:0043219 | lateral loop(GO:0043219) |
| 0.0 | 0.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.0 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.0 | 0.4 | GO:0031045 | dense core granule(GO:0031045) |
| 0.0 | 0.1 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.0 | 2.2 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.0 | 0.5 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.0 | 1.0 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.0 | 0.4 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.0 | 8.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.0 | 0.3 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
| 0.0 | 0.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.0 | 1.0 | GO:0000793 | condensed chromosome(GO:0000793) |
| 0.0 | 0.8 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 0.2 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.0 | 1.3 | GO:0044448 | cell cortex part(GO:0044448) |
| 0.0 | 0.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.5 | 22.2 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 2.9 | 8.6 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 2.4 | 7.3 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 2.4 | 7.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 2.4 | 11.8 | GO:0010736 | serum response element binding(GO:0010736) |
| 1.9 | 9.7 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 1.9 | 5.8 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 1.8 | 7.3 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 1.7 | 5.0 | GO:0070123 | transforming growth factor beta receptor activity, type III(GO:0070123) |
| 1.7 | 5.0 | GO:0015039 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
| 1.5 | 6.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 1.5 | 1.5 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
| 1.4 | 4.2 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 1.3 | 10.1 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 1.2 | 3.7 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
| 1.2 | 4.8 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 1.2 | 3.6 | GO:0047291 | neolactotetraosylceramide alpha-2,3-sialyltransferase activity(GO:0004513) lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
| 1.2 | 2.4 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 1.2 | 5.9 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 1.2 | 4.7 | GO:0004057 | arginyltransferase activity(GO:0004057) |
| 1.1 | 4.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 1.1 | 3.2 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
| 1.0 | 3.1 | GO:0036440 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
| 1.0 | 6.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.9 | 3.8 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
| 0.9 | 2.8 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity(GO:0043337) |
| 0.9 | 4.6 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
| 0.9 | 5.4 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.9 | 9.0 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.9 | 2.7 | GO:0004584 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity(GO:0004584) |
| 0.9 | 4.4 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 0.9 | 6.9 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.8 | 14.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.8 | 3.2 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.8 | 4.7 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.7 | 11.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.7 | 2.2 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
| 0.7 | 6.4 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.7 | 5.6 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.7 | 16.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.7 | 2.7 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
| 0.7 | 2.0 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.7 | 3.4 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.7 | 2.7 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
| 0.7 | 2.0 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 0.7 | 2.6 | GO:0032427 | GBD domain binding(GO:0032427) |
| 0.6 | 5.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.6 | 1.9 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
| 0.6 | 2.5 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.6 | 1.8 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.6 | 1.8 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.6 | 1.8 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
| 0.6 | 4.7 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.6 | 1.8 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 0.6 | 6.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.6 | 4.0 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.6 | 2.8 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.6 | 2.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.5 | 4.8 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.5 | 2.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.5 | 4.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.5 | 2.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.5 | 2.1 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.5 | 2.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.5 | 1.5 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.5 | 4.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.5 | 6.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.5 | 3.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.5 | 4.3 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.5 | 10.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.4 | 1.8 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.4 | 4.0 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.4 | 3.4 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.4 | 3.8 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.4 | 1.7 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.4 | 0.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.4 | 1.2 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 0.4 | 9.4 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.4 | 1.2 | GO:0015068 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
| 0.4 | 3.2 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.4 | 7.9 | GO:0005522 | profilin binding(GO:0005522) |
| 0.4 | 2.6 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.4 | 10.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.4 | 1.1 | GO:0086039 | lutropin-choriogonadotropic hormone receptor binding(GO:0031775) calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential(GO:0086039) |
| 0.4 | 11.9 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.4 | 1.1 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 0.4 | 3.3 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.4 | 4.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.4 | 1.4 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.4 | 4.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.4 | 10.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.3 | 3.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.3 | 5.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.3 | 10.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.3 | 3.7 | GO:0003909 | DNA ligase activity(GO:0003909) |
| 0.3 | 3.3 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.3 | 10.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.3 | 8.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.3 | 1.5 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.3 | 11.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.3 | 0.9 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.3 | 5.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.3 | 1.5 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.3 | 4.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.3 | 1.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.3 | 5.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.3 | 0.9 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.3 | 0.9 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.3 | 7.8 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.3 | 4.6 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.3 | 1.1 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.3 | 1.4 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.3 | 2.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.3 | 3.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.3 | 2.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.3 | 0.8 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.3 | 1.9 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.3 | 11.0 | GO:0005521 | lamin binding(GO:0005521) |
| 0.3 | 5.9 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.3 | 2.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.3 | 4.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.3 | 2.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.3 | 2.3 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.3 | 2.9 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.3 | 2.6 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.2 | 7.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.2 | 2.0 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.2 | 2.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.2 | 2.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.2 | 1.5 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.2 | 1.7 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.2 | 1.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.2 | 3.3 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.2 | 4.4 | GO:0035173 | histone kinase activity(GO:0035173) |
| 0.2 | 3.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 0.2 | 2.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.2 | 2.3 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 0.2 | 1.8 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.2 | 3.0 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.2 | 0.9 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.2 | 3.6 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.2 | 1.8 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.2 | 6.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.2 | 3.0 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.2 | 1.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.2 | 5.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.2 | 0.6 | GO:0032142 | single guanine insertion binding(GO:0032142) single thymine insertion binding(GO:0032143) |
| 0.2 | 1.1 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.2 | 1.7 | GO:0003774 | motor activity(GO:0003774) |
| 0.2 | 0.6 | GO:0019961 | interferon binding(GO:0019961) |
| 0.2 | 0.8 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
| 0.2 | 1.6 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
| 0.2 | 3.7 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.2 | 1.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.2 | 0.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.2 | 0.8 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 0.2 | 1.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.2 | 1.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.2 | 0.8 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
| 0.2 | 1.0 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.2 | 1.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.2 | 1.8 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.2 | 1.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.2 | 2.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.2 | 3.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.2 | 0.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.2 | 1.1 | GO:0052845 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.2 | 0.6 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
| 0.2 | 1.1 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.2 | 0.5 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 0.2 | 2.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.2 | 2.5 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
| 0.2 | 0.5 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.2 | 0.5 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.2 | 2.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.2 | 0.3 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.2 | 0.8 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.2 | 1.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.2 | 1.5 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.2 | 1.6 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.2 | 1.7 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.2 | 4.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.2 | 1.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.2 | 1.8 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.1 | 0.9 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 0.1 | 4.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.1 | 8.2 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 0.1 | 7.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 1.8 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.1 | 11.4 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.1 | 0.4 | GO:0004103 | choline kinase activity(GO:0004103) |
| 0.1 | 1.0 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.1 | 1.0 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.1 | 0.9 | GO:0005113 | patched binding(GO:0005113) |
| 0.1 | 1.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.1 | 9.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 1.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.1 | 1.7 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.1 | 1.0 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.1 | 1.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.1 | 5.0 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.1 | 2.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.1 | 1.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.1 | 0.4 | GO:0051765 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol tetrakisphosphate kinase activity(GO:0051765) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
| 0.1 | 4.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.1 | 6.2 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.1 | 0.1 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.1 | 3.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.1 | 1.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.1 | 10.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.1 | 3.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.1 | 0.4 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
| 0.1 | 6.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.1 | 0.7 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.1 | 0.7 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 0.1 | 4.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.1 | 2.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.1 | 1.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.1 | 2.1 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
| 0.1 | 0.5 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.1 | 0.9 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.1 | 8.6 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.1 | 0.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.1 | 0.5 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.1 | 0.3 | GO:0030395 | lactose binding(GO:0030395) |
| 0.1 | 4.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.1 | 2.8 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.1 | 1.1 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
| 0.1 | 0.7 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.1 | 0.7 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.1 | 1.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.1 | 2.2 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.1 | 0.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.1 | 0.4 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.1 | 1.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.1 | 0.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.1 | 0.5 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.1 | 1.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.1 | 0.5 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.1 | 2.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.1 | 0.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.1 | 0.6 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.1 | 1.9 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.1 | 0.3 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.1 | 10.3 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.1 | 1.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.1 | 11.7 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.1 | 1.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.1 | 3.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 3.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.1 | 4.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.1 | 2.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.1 | 2.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.1 | 0.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.1 | 2.6 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.1 | 2.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.1 | 0.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.1 | 5.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.1 | 1.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.1 | 0.5 | GO:0097001 | ceramide binding(GO:0097001) |
| 0.1 | 4.0 | GO:0004386 | helicase activity(GO:0004386) |
| 0.1 | 0.4 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.1 | 1.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.1 | 0.8 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
| 0.1 | 0.7 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.1 | 5.4 | GO:0019003 | GDP binding(GO:0019003) |
| 0.1 | 2.8 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.1 | 4.4 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.1 | 5.6 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
| 0.1 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.1 | 1.7 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.1 | 12.8 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
| 0.1 | 0.6 | GO:0071253 | connexin binding(GO:0071253) |
| 0.1 | 0.8 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.1 | 2.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.1 | 4.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.1 | 1.4 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.1 | 2.4 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.1 | 0.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.1 | 9.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.1 | 0.1 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.1 | 0.7 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.1 | 0.7 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.1 | 0.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.1 | 0.8 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.1 | 0.4 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 0.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.1 | 2.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.1 | 1.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.1 | 5.9 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.1 | 0.7 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.1 | 0.5 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.1 | 0.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 0.3 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.1 | 1.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.1 | 1.1 | GO:0005537 | mannose binding(GO:0005537) |
| 0.1 | 0.2 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
| 0.1 | 4.3 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
| 0.1 | 0.2 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.1 | 0.3 | GO:0052744 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
| 0.1 | 1.6 | GO:0019841 | retinol binding(GO:0019841) |
| 0.1 | 0.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.1 | 1.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.1 | 0.5 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.1 | 0.4 | GO:0016531 | copper chaperone activity(GO:0016531) |
| 0.1 | 1.3 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.1 | 0.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.1 | 0.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 0.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.1 | 0.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.1 | 3.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.1 | 1.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.1 | 0.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.1 | 0.4 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 0.1 | 0.4 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.1 | 1.3 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.1 | 1.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.1 | 0.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.1 | 0.3 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.1 | 0.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.1 | 0.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.1 | 3.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.1 | 0.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.1 | 1.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.1 | 0.4 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.0 | 0.4 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.0 | 1.7 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.0 | 7.6 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.0 | 0.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.0 | 0.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.0 | 0.9 | GO:0008061 | chitin binding(GO:0008061) |
| 0.0 | 0.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.0 | 0.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 0.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.0 | 0.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.0 | 0.8 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.0 | 0.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.0 | 1.0 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
| 0.0 | 0.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.0 | 1.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.0 | 2.0 | GO:0016504 | peptidase activator activity(GO:0016504) |
| 0.0 | 1.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.0 | 4.4 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.0 | 0.9 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.0 | 0.1 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.0 | 3.2 | GO:0051117 | ATPase binding(GO:0051117) |
| 0.0 | 0.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.0 | 0.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.0 | 1.4 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.0 | 1.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
| 0.0 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.0 | 7.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 0.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.0 | 0.2 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.0 | 1.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.0 | 0.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.0 | 0.2 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.0 | 9.9 | GO:0015631 | tubulin binding(GO:0015631) |
| 0.0 | 3.0 | GO:0017022 | myosin binding(GO:0017022) |
| 0.0 | 0.3 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.0 | 0.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.0 | 1.0 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.0 | 0.1 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.0 | 0.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
| 0.0 | 0.2 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 0.0 | 0.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.0 | 0.8 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.0 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.0 | 2.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.0 | 0.3 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.0 | 0.1 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.0 | 1.0 | GO:0015085 | calcium ion transmembrane transporter activity(GO:0015085) |
| 0.0 | 0.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.0 | 0.8 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.0 | 0.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.0 | 1.7 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
| 0.0 | 0.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.0 | 3.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.0 | 0.4 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.0 | 2.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.0 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.0 | 0.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.0 | 1.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.0 | 0.2 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.0 | 0.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.0 | 0.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.4 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
| 0.0 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.0 | 1.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.0 | 0.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.0 | 0.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.0 | 0.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.0 | 1.1 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.0 | 0.7 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.0 | 0.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.0 | 0.1 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
| 0.0 | 0.4 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
| 0.0 | 0.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.0 | 0.4 | GO:0043531 | ADP binding(GO:0043531) |
| 0.0 | 0.4 | GO:0030276 | clathrin binding(GO:0030276) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 12.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.5 | 13.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.5 | 11.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.5 | 0.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.4 | 5.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.3 | 6.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.3 | 0.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.3 | 19.6 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.3 | 11.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.3 | 22.1 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.2 | 31.3 | PID E2F PATHWAY | E2F transcription factor network |
| 0.2 | 8.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.2 | 11.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.2 | 1.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.2 | 10.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.2 | 16.5 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.2 | 6.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.2 | 7.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.2 | 9.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.2 | 5.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.2 | 1.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.2 | 5.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.1 | 12.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.1 | 5.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.1 | 19.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.1 | 5.5 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.1 | 5.7 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.1 | 15.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.1 | 1.9 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 2.4 | PID BMP PATHWAY | BMP receptor signaling |
| 0.1 | 4.4 | PID ATR PATHWAY | ATR signaling pathway |
| 0.1 | 1.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.1 | 5.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 1.1 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.1 | 10.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.1 | 3.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.1 | 3.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.1 | 10.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.1 | 1.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.1 | 4.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 4.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.1 | 1.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.1 | 1.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.1 | 8.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.1 | 1.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 1.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 3.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.1 | 0.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.1 | 3.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.1 | 0.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.1 | 1.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.1 | 5.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.1 | 0.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.1 | 0.7 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.1 | 0.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 1.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.1 | 4.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.1 | 0.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 3.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.1 | 1.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.1 | 2.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.1 | 2.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.1 | 2.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.1 | 1.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.1 | 0.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.0 | 1.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.0 | 1.3 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.0 | 2.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 2.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 2.5 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.0 | 1.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.0 | 1.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.0 | 1.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.0 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.0 | 1.0 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.0 | 5.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.6 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.0 | 0.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.6 | 24.6 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 0.8 | 24.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.7 | 13.9 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
| 0.5 | 7.7 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.5 | 2.4 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
| 0.5 | 2.4 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 0.5 | 13.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.5 | 3.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.4 | 7.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.4 | 15.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.4 | 8.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.4 | 6.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.4 | 5.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.4 | 6.0 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
| 0.4 | 23.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.4 | 4.6 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 0.3 | 5.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
| 0.3 | 3.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.3 | 8.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.3 | 12.3 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.3 | 9.4 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.3 | 7.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.3 | 11.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.2 | 17.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.2 | 3.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.2 | 1.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.2 | 5.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.2 | 14.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.2 | 4.9 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.2 | 11.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.2 | 1.4 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
| 0.2 | 1.7 | REACTOME OPSINS | Genes involved in Opsins |
| 0.2 | 9.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.2 | 18.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.2 | 6.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.2 | 5.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.2 | 13.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.2 | 0.3 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.2 | 7.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.2 | 1.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.2 | 4.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.2 | 2.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.1 | 3.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.1 | 3.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.1 | 6.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.1 | 4.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.1 | 2.2 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
| 0.1 | 2.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.1 | 0.6 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
| 0.1 | 3.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.1 | 0.9 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
| 0.1 | 8.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.1 | 6.8 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.1 | 10.2 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.1 | 5.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.1 | 4.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.1 | 3.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.1 | 0.7 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
| 0.1 | 2.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.1 | 5.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.1 | 3.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.1 | 3.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.1 | 1.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.1 | 1.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.1 | 2.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.1 | 1.0 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.1 | 2.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 3.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.1 | 2.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.1 | 2.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.1 | 3.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.1 | 3.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.1 | 1.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
| 0.1 | 0.8 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.1 | 3.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.1 | 1.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.1 | 3.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 2.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.1 | 3.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.1 | 1.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.1 | 1.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.1 | 1.1 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
| 0.1 | 3.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 5.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.1 | 0.7 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
| 0.1 | 2.4 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.1 | 3.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.1 | 3.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.1 | 4.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 0.7 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.1 | 0.5 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.1 | 1.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.1 | 0.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.1 | 1.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.1 | 4.2 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
| 0.1 | 3.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.1 | 4.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.1 | 1.2 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
| 0.1 | 1.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.1 | 0.5 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.1 | 4.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.1 | 1.3 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
| 0.1 | 0.6 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
| 0.1 | 3.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.1 | 1.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.1 | 3.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.0 | 0.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.0 | 0.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.0 | 1.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.0 | 1.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.0 | 1.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.0 | 1.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.0 | 1.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.0 | 0.5 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.0 | 3.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.0 | 1.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.0 | 6.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.0 | 2.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.0 | 0.5 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 0.0 | 1.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.0 | 1.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.0 | 8.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.0 | 0.7 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
| 0.0 | 1.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.0 | 1.1 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.0 | 0.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.0 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.0 | 0.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.0 | 0.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.0 | 1.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.0 | 0.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.0 | 0.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.0 | 1.7 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.0 | 0.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.0 | 0.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.0 | 0.9 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
| 0.0 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.0 | 0.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.0 | 2.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 0.2 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
| 0.0 | 0.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 0.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.0 | 1.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 0.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.0 | 0.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.0 | 0.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.0 | 1.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.0 | 0.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |